Switching from TNFα inhibitor to tacrolimus as maintenance therapy in rheumatoid arthritis after achieving low disease activity with TNFα inhibitors and methotrexate: 24-week result from a non-randomized, prospective, active-controlled trial

BACKGROUND: Tapering or stopping biological disease-modifying anti-rheumatic drugs has been proposed for patients with rheumatoid arthritis (RA) in remission, but it frequently results in high rates of recurrence. This study evaluates the efficacy and safety of tacrolimus (TAC) as maintenance therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Sang Youn, Koh, Jung Hee, Kim, Ki-Jo, Park, Yong-Wook, Yang, Hyung-In, Choi, Sung Jae, Lee, Jisoo, Choi, Chan-Bum, Kim, Wan-Uk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265052/
https://www.ncbi.nlm.nih.gov/pubmed/34233727
http://dx.doi.org/10.1186/s13075-021-02566-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265052/
https://www.ncbi.nlm.nih.gov/pubmed/34233727
http://dx.doi.org/10.1186/s13075-021-02566-z

Ejemplares similares